![Machine learning models to accelerate the design of polymeric long-acting injectables | Nature Communications Machine learning models to accelerate the design of polymeric long-acting injectables | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-35343-w/MediaObjects/41467_2022_35343_Fig1_HTML.png)
Machine learning models to accelerate the design of polymeric long-acting injectables | Nature Communications
![Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies | Nature Medicine Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnm.4444/MediaObjects/41591_2017_Article_BFnm4444_Fig1_HTML.jpg)
Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies | Nature Medicine
![Combi-seq for multiplexed transcriptome-based profiling of drug combinations using deterministic barcoding in single-cell droplets | Nature Communications Combi-seq for multiplexed transcriptome-based profiling of drug combinations using deterministic barcoding in single-cell droplets | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-32197-0/MediaObjects/41467_2022_32197_Fig1_HTML.png)
Combi-seq for multiplexed transcriptome-based profiling of drug combinations using deterministic barcoding in single-cell droplets | Nature Communications
![MuSyC is a consensus framework that unifies multi-drug synergy metrics for combinatorial drug discovery | Nature Communications MuSyC is a consensus framework that unifies multi-drug synergy metrics for combinatorial drug discovery | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-021-24789-z/MediaObjects/41467_2021_24789_Fig1_HTML.png)
MuSyC is a consensus framework that unifies multi-drug synergy metrics for combinatorial drug discovery | Nature Communications
![Synergistic drug combinations tend to improve therapeutically relevant selectivity | Nature Biotechnology Synergistic drug combinations tend to improve therapeutically relevant selectivity | Nature Biotechnology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnbt.1549/MediaObjects/41587_2009_Article_BFnbt1549_Fig1_HTML.jpg)
Synergistic drug combinations tend to improve therapeutically relevant selectivity | Nature Biotechnology
![MuSyC is a consensus framework that unifies multi-drug synergy metrics for combinatorial drug discovery | Nature Communications MuSyC is a consensus framework that unifies multi-drug synergy metrics for combinatorial drug discovery | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-021-24789-z/MediaObjects/41467_2021_24789_Fig5_HTML.png)
MuSyC is a consensus framework that unifies multi-drug synergy metrics for combinatorial drug discovery | Nature Communications
![A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia | Nature Medicine A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-01819-x/MediaObjects/41591_2022_1819_Fig1_HTML.png)
A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia | Nature Medicine
![A machine learning-based chemoproteomic approach to identify drug targets and binding sites in complex proteomes | Nature Communications A machine learning-based chemoproteomic approach to identify drug targets and binding sites in complex proteomes | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-020-18071-x/MediaObjects/41467_2020_18071_Fig1_HTML.png)
A machine learning-based chemoproteomic approach to identify drug targets and binding sites in complex proteomes | Nature Communications
![A guide to cancer immunotherapy: from T cell basic science to clinical practice | Nature Reviews Immunology A guide to cancer immunotherapy: from T cell basic science to clinical practice | Nature Reviews Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41577-020-0306-5/MediaObjects/41577_2020_306_Fig1_HTML.png)
A guide to cancer immunotherapy: from T cell basic science to clinical practice | Nature Reviews Immunology
![DNA-encoded chemistry: enabling the deeper sampling of chemical space | Nature Reviews Drug Discovery DNA-encoded chemistry: enabling the deeper sampling of chemical space | Nature Reviews Drug Discovery](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrd.2016.213/MediaObjects/41573_2017_Article_BFnrd2016213_Fig1_HTML.jpg)
DNA-encoded chemistry: enabling the deeper sampling of chemical space | Nature Reviews Drug Discovery
![Determination of the ratio of drug combinations to induce synergy. (A,... | Download Scientific Diagram Determination of the ratio of drug combinations to induce synergy. (A,... | Download Scientific Diagram](https://www.researchgate.net/profile/Yarong-Liu-3/publication/267346881/figure/fig2/AS:613890572419093@1523374326762/Determination-of-the-ratio-of-drug-combinations-to-induce-synergy-A-B-In-vitro_Q640.jpg)
Determination of the ratio of drug combinations to induce synergy. (A,... | Download Scientific Diagram
![Network-based approach to prediction and population-based validation of in silico drug repurposing | Nature Communications Network-based approach to prediction and population-based validation of in silico drug repurposing | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-018-05116-5/MediaObjects/41467_2018_5116_Fig1_HTML.jpg)
Network-based approach to prediction and population-based validation of in silico drug repurposing | Nature Communications
![A unified drug–target interaction prediction framework based on knowledge graph and recommendation system | Nature Communications A unified drug–target interaction prediction framework based on knowledge graph and recommendation system | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-27137-3/MediaObjects/41467_2021_27137_Fig1_HTML.png)
A unified drug–target interaction prediction framework based on knowledge graph and recommendation system | Nature Communications
![The landscape of receptor-mediated precision cancer combination therapy via a single-cell perspective | Nature Communications The landscape of receptor-mediated precision cancer combination therapy via a single-cell perspective | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-29154-2/MediaObjects/41467_2022_29154_Fig1_HTML.png)
The landscape of receptor-mediated precision cancer combination therapy via a single-cell perspective | Nature Communications
![The implications of target saturation for the use of drug–target residence time | Nature Reviews Drug Discovery The implications of target saturation for the use of drug–target residence time | Nature Reviews Drug Discovery](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnrd.2018.234/MediaObjects/41573_2019_Article_BFnrd2018234_Fig1_HTML.jpg)